New modalities in the salvage of recurrent nasopharyngeal carcinoma

Similar documents
EFFICACY OF NECK DISSECTION FOR LOCOREGIONAL FAILURES VERSUS ISOLATED NODAL FAILURES IN NASOPHARYNGEAL CARCINOMA

Nasopharynx Cancer. 1 Feb Presenters: Dr Raghav Murali-Ganesh (Radiation Oncology Registrar) Dr Peter Luk (Pathology Registrar)

Considerations in Oncologic Resection (mandible & maxilla)

Long-Term Outcomes of Nasopharyngectomy Using Partial Maxillectomy Approach

STEREOTACTIC RADIOSURGERY PLUS INTRACAVITARY IRRADIATION IN THE SALVAGE OF NASOPHARYNGEAL CARCINOMA

Salvage surgery for nasopharyngeal cancer

Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment

INTRODUCTION. KEY WORDS: nasopharyngeal carcinoma, recurrence, intensitymodulated radiotherapy (IMRT), endoscopic nasopharyngectomy

RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.

ORIGINAL ARTICLE. Nasopharyngectomy for Recurrent Nasopharyngeal Cancer

Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma

Nasopharyngeal Cancer/Multimodality Treatment

NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)

Rola brachyterapii w leczeniu wznów nowotworów języka i dna jamy ustnej. The role of brachytherapy in recurrent. oral cavity

ESMO Perceptorship H&N cancer Epidemiology, Anatomy and Workup 16 March 2018

Enterprise Interest None

Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma

Northern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer

Current treatment options for local residual nasopharyngeal carcinoma

NASOPHARYNX MALIGNANT NEOPLASM MOHAMMED ALESSA MBBS, FRCSC ASSISTANT PROFESSOR, CONSULTANT OTOLARYNGOLOGY, HEAD & NECK SURGRY KING SAUD UNIVERSITY

Summary. Joanna Terlikiewicz 1,2, Roman Makarewicz 1,2, Andrzej Lebioda 1,2, Renata Kabacińska 2,3, Marta Biedka 2

Nasopharynx. 1. Introduction. 1.1 General Information and Aetiology

ESMO Preceptorship Program Head & Neck Cancer NPC: Epidemiology, diagnosis and work-up

ESMO Preceptorship Program Head & Neck Cancer NPC: Epidemiology, diagnosis and work-up

Might Adaptive Radiotherapy in NSCLC be feasible in clinical practice?

ABSTRACT INTRODUCTION

Head and Neck Reirradiation: Perils and Practice

Radiation therapy for locoregionally advanced nasopharyngeal carcinoma in elderly patients

Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

Stereotactic radiotherapy

WHAT DOES PET IMAGING ADD TO CONVENTIONAL STAGING OF HEAD AND NECK CANCER PATIENTS?

Recent advances in the management of nasopharyngeal carcinoma. Citation Hong Kong Practitioner, 1998, v. 20 n. 5, p

From GTV to CTV: A Critical Step Towards Cure. Kenneth Hu, MD Associate Professor New York University Langone Medical Center June 21, 2017

Collection of Recorded Radiotherapy Seminars

Clinical and imaging characteristics of 53 ulcers of post radiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma

Hong Kong Hospital Authority Convention 2018

European Journal of Radiology

Disclosures. Overview 8/3/2016. SRS: Cranial and Spine

CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Trimodality Therapy for Muscle Invasive Bladder Cancer

PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

Clinical Trials in Transoral Endoscopic Head &Neck Surgery ECOG3311 and RTOG1221. Chris Holsinger, MD, FACS Bob Ferris, MD, PhD, FACS

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Goals and Objectives: Head and Neck Cancer Service Department of Radiation Oncology

Country Presentations of FNCA FY2007 Workshop on Radiation Oncology

CT PET SCANNING for GIT Malignancies A clinician s perspective

Locoregional recurrences are the most frequent

Piero Nicolai SURGERY FOR THE TREATMENT OF OROPHARYNGEAL CARCINOMA: STATE OF ART. Department of Otorhinolaryngology University of Brescia

Neck Dissection. Asst Professor Jeeve Kanagalingam MA (Cambridge), BM BCh (Oxford), MRCS (Eng), DLO, DOHNS, FRCS ORL-HNS (Eng), FAMS (ORL)

Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience

Re-irradiation with or without chemotherapy. Jozsef Lövey National Institute of Oncology, Budapest, Hungary

肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部

Brachytherapy for Bladder carcinoma

MAIN ARTICLE S-T TOH 1, H-W YUEN 3, K-H LIM 2, Y-H GOH 1, H-K C GOH 1

The Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology

Clinically Proven Metabolically-Guided TomoTherapy SM Treatments Advancing Cancer Care

De-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist

Utilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D.

Prostate Cancer Local or distant recurrence?

Int J Clin Exp Med 2017;10(1): /ISSN: /IJCEM Jun Lv, Lingjiang Pan, Jiamei Lu, Wen Qin, Tingting Zhang

State of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

Update on Sarcomas of the Head and Neck. Kevin Harrington

Radiation Therapy for Soft Tissue Sarcomas

Concomitant Radiochemotherapy in the Management of Nasopharyngeal Carcinoma

ORIGINAL ARTICLE. among populations originating from southern China and their descendants who have emigrated to other parts of the world.

Local control in advanced cancer of the nasopharynx: Is a boost dose by endocavitary brachytherapy of prognostic significance?

Adjuvant Chemotherapy for Rectal Cancer: Are we making progress?

Combining chemotherapy and radiotherapy of the chest

IAEA RTC. PET/CT and Planning of Radiation Therapy 20/08/2014. Sarajevo (Bosnia & Hercegovina) Tuesday, June :40-12:20 a.

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy

Ruolo dell imaging nella pianificazione del trattamento

Cervical Cancer Guidelines L and SC Network July Introduction:

Tsang, RK; Kwong, DL; Ho, AC; To, VS; Ho, WK; Wei, WI

Vincent Grégoire, Radiation Oncologist, Brussels, Belgium Cai Grau, Radiation Oncologist, Aarhus, Denmark. Tunis March 2017

Clinical Significance of Quantitative Analysis of EBV DNA in Plasma of NPC Patients After Curative Radiotherapy

ORIGINAL ARTICLE BRACHYTHERAPY BOOST FOR T1/T2 NASOPHARYNGEAL CARCINOMA

RADIATION-INDUCED CRANIAL NERVE PALSY: A CROSS-SECTIONAL STUDY OF NASOPHARYNGEAL CANCER PATIENTS AFTER DEFINITIVE RADIOTHERAPY

ESMO Preceptorship Programme

Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015

Neck Imaging Reporting and Data System: An Atlas of NI-RADS Categories for Head and Neck Cancer

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data

Original Article. Yuri Jeong, MD 1, Sang-wook Lee, MD, PhD 2. Introduction

The Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.

Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer

Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh

How to Manage a Case of Stage-I Oropharyngeal Cancer with Very Close Cutting End Post-Operatively?

Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma

San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy

Laryngeal Preservation Using Radiation Therapy. Chemotherapy and Organ Preservation

S249 FACTORS TO GUIDE CLINICAL USE OF EPSTEIN-BARR VIRUS DNA LOAD IN THE DETECTION OF RECURRENT NASOPHARYNGEAL CARCINOMA.

The Physics of Oesophageal Cancer Radiotherapy

ONCOLOGY LETTERS 10: , 2015

TREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy

Clinical Implications Of Dose Summation And Adaptation

Transcription:

New modalities in the salvage of recurrent nasopharyngeal carcinoma Dr Jeeve Kanagalingam FRCS Eng (ORL-HNS) Department of Otorhinolaryngology Tan Tock Seng Hospital SINGAPORE

Nasopharyngeal carcinoma is endemic in Singapore Over 93% are of the radiosensitive WHO type III histological variety In Chinese men, rates have declined since 1992 Population Hong Kong 21.4 Singapore Chinese 16.3 Shanghai 4.2 NSW, Australia 0.9 Incidence (per 100,000) 1993-97 Age standardised rates (ASR) in Singapore Chinese men Period ASR 1988-1992 18.7 1998-2002 12.5 Source: Singapore Cancer Registry Report No. 6: Trends in Cancer Incidence in Singapore 1968-2002. A Seow et. al.

IMRT - standard of care in Singapore since 2006 Intergroup 0099 protocol was validated in Singapore in 2005 (J Wee et. al. J Clin Oncol) Local results are comparable to other studies in endemic populations Survival Outcome 1-year 3-year Overall 98.4% 94.3% Local recurrence free 96.8% 89.6% Distant relapse-free 96.8% 89.2% Disease-free 93.7% 79.0% Source: Treatment of Nasopharyngeal Carcinoma using Intensity-Modulated Radiotherapy The National Cancer Centre Singapore Experience. Tham IW et. al. Int J Rad Onc Biol Phys 2009

Locally persistent or recurrent 9-40% in most studies 10 12% with new RT methods disease is a problem But 73% of local failures had no evidence of distant or regional disease Source: Treatment of Nasopharyngeal Carcinoma using Intensity-Modulated Radiotherapy The National Cancer Centre Singapore Experience. Tham IW et. al. Int J Rad Onc Biol Phys 2009

Recurrence can occur late N=847 local recurrences Time post commencement RT > 2 years 52% 2-5 years 39% >5 years 9% Percentage of local recurrence Source: Recurrent nasopharyngeal carcinoma: the puzzles of long latency Lee AW et. al. Int J Rad Onc Biol Phys 1999

New modalities that may make a difference Early detection of recurrence Radiotherapy Surgery

Nasal endoscopy, CT and MRI widely used but not reliable

Nasal endoscopy, CT and MRI widely used but not reliable Nasal endoscopy in NPC follow-up Sensitivity Specificity PPV NPV Ragab SM (2008) 67% 95% 67% 95% Kwong DL (2001) 29% 86% 35% 82% CT and MR in NPC follow-up False + False - CT 71% 33% MRI 17% 14% Chong VFH (1997)

FDG-PET/CT offers early detection In a systematic review of 21 studies, PET more sensitive than MR or CT of recurrence CT MR PET Sensitivity 76% 78% 95% SUV > 4, 3 months post-rt Source: FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Liu T et. al. Radiother Oncol 2007

Contact rhinoscopy Has been evaluated in irradiated patients Diagnostic accuracy of 92.1% Correlates well with histology (kappa coefficient=0.847) Sensitivity = 100% Specificity = 100% Source: In vivo diagnosis of persistent and recurrent nasopharyngeal carcinoma by contact endoscopy. Pak MW et. al. Laryngoscope 2002

New modalities that may make a difference Early detection of recurrence Radiotherapy Surgery

Re-irradiation with IMRT Present method of choice in cases not amenable to surgery TED > 55-60 Gy is critical

Re-irradiation with IMRT Author n Median FU 3-year survival Lu, 2004 49 0.75 100% control at 0.75 years Chua, 2005 Koutcher, 2009 31 0.92 30-40% at 2 years 5-year survival Stage I/II Stage II/IV - 27% 73% 6% - 26% 74% 68% 29 3.75 71% 60% 52% 48% 93% Percentage receiving Chemo

Stereotactic Radiosurgery (SRS) Fractionated Stereotactic RT (FSRT) Author n Modality Median FU Pai, 2002 Shin, 2004 Low, 2006 Wu, 2007 Chua, 2007 Leung, 2009 3-year survival 5-year survival Stage I/II Stage III/IV 36 SRS 1.8 54% 31% 64% 36% 21 FSRT 4.1-32% 48% 52% 25 SRS/BT 4.2-53% 100% 0% 56 FSRT 3.3 46% - 68% 32% 74 SRS/BT 3.5 66-78% - 70% 30% 30 SRS - 65-67% 40% 70% 30%

New modalities that may make a difference Early detection of recurrence Radiotherapy Surgery

Nasopharyngectomy: Radiation-sparring surgery? Ideal for rt1, rt2a and selected rt2b, rt3 cases Aim to achieve clear margins and spare re-rt May not improve survival Hopefully improves QOL Source: How successful is high-dose (> 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Teo PM et. al. (1998) Int J Radiat Oncol Biol Phys

Conventional approaches can incur For radical resection Maxillary swing Transpalataltransmandibular significant morbidity Mid-facial degloving Lateral approach Maxillary swing approach gives better survival for early stage recurrence Source: Nasopharyngectomy: Does the approach to the nasopharynx influence survival? Vlantis AC et. al. (2008) Otolaryngology Head and Neck Surgery

Complications are common Fee s series of 37 cases had complication rate of 54% In King s series, the following complications were noted Soft palate dysfunction (54.8%) Trismus (48.4%) Dysphagia (38.7%) Nasal regurgitation (25.8%) Source: Nasopharyngectomy for recurrent NPC a 2-17 year follow-up. Fee WE et. al. (2002) Nasopharyngectomy in the treatment of recurrent NPC: a 12 year experience. King WW (2000)

Endoscopic Nasopharyngectomy n = 37 patients Recurrent T stage Number rt1 17 rt2a 4 rt2b 14 rt3 2 30/37 Previous RT 7/37 RT X 2 En bloc resection with negative margin in 35/37 195 minutes, 115 mls blood loss None had further RT Survival at 2 years Percentage Overall 84.2% Local relapse-free 86.3% Progression-free 82.6% Source: Endoscopic Nasopharyngectomy for Locally Recurrent Nasopharyngeal Carcinoma. Chen M-Y et. al. (2009) Laryngoscope

For larger tumours recurrences No clinical studies Cadaveric dissections show that it is feasible Transoral robotic nasopharyngectomy? Source: Transoral Robotic Nasopharyngectomy: A Novel Approach for Nasopharyngeal Lesions. Ozer E & Waltonen J (2008). Laryngoscope

Summary Early detection is probably the most important factor in managing recurrences Oncologically sound minimally invasive surgery will spare early recurrences reirradiation New RT modalities should aim to improve QOL